The Kpm Group DC LLC
$8.1M
Total Income
34
Clients
13
Lobbyists
241
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2019 | $10K |
| 2020 | $560K |
| 2021 | $1.7M |
| 2022 | $1.5M |
| 2023 | $1.6M |
| 2024 | $1.7M |
| 2025 | $960K |
Clients
Alexion PharmaceuticalsOpiant PharmaceuticalsUltragenyx PharmaceuticalOvid TherapeuticsZambon USASummit Therapeutics PLCAeglea Biotherapeutics, INC.Gritstone OncologyChiesi USA, INC.Pharmaessentia CorporationAcceleron PharmaSangamo Therapeutics, INCOrphazyme US, INC.Mannkind CorporationBioagilytix Labs, LLCThe Brain Donor ProjectAtai Life Sciences N.V.Rare Disease Company CoalitionNational Board for Certified Counselors and Affiliates, INC.Relmada Therapeutics, INC.Cognoa, INC.Fulcrum Therapeutics, INC.Stealth Biotherapeutics INC.Soleno Therapeutics, INC.Praxis Precision MedicinesJeremy LevinGensight Biologics S.A.Mind Medicine INC.RezoluteAstria Therapeutics, INC.Sebela PharmaceuticalsRocket Pharmaceuticals, INC.The Hs CoalitionInozyme Pharma
Lobbyists
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.